Generic Product News (August 2017)

Pharmacy Times, August 2017 Pain Awareness, Volume 83, Issue 8

Read about the new generic products featured in August.

: Taro Pharmaceutical Industries

COMPARE TO: Tazorac (Allergan)

INDICATION: Taro has launched an AB-rated generic version of Allergan’s Tazorac (tazarotene) 0.1% topical cream. Tazorac 0.1% is indicated for the topical treatment of patients with plaque psoriasis and acne vulgaris.

DOSAGE FORM: Topical cream: 0.1%

FOR MORE INFORMATION: taro.com

EZETIMIBE TABLETSMARKETED BY: Teva Pharmaceuticals

COMPARE TO: Zetia (Merck)

INDICATION: Teva has announced the US launch of generic Zetia (ezetimibe) tablets, 10 mg. Ezetimibe tablets are indicated to lower levels of total cholesterol and low-density lipoprotein cholesterol in the blood. Ezetimibe tablets are for patients who cannot control their cholesterol levels by diet and exercise alone.

DOSAGE FORM: Tablets: 10 mg

FOR MORE INFORMATION: tevapharm.com

PERPHENAZINEMARKETED BY: Teva Pharmaceuticals

COMPARE TO: Trilafon (Merck)

INDICATION: Teva has launched its generic of Trilafon (perphenazine) tablets. The drug is indicated to treat schizophrenia and to control severe nausea and vomiting in adults. DOSAGE FORM: Tablets: 2, 4, 8, and 16 mg

FOR MORE INFORMATION: tevapharm.com

ACYCLOVIRMARKETED BY: Taro Pharmaceutical Industries

COMPARE TO: Zovirax (Valeant)

INDICATION: Taro has launched its generic of Zovirax (acyclovir) ointment, 5%. The drug is indicated in the management of initial genital herpes and in limited nonlife-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients.

DOSAGE FORM: Topical: ½-inch ribbon of ointment per 4 square inches of surface area

FOR MORE INFORMATION: taro.com